DFX Intelligence
Venture Capital Intelligence
Firms, funds, partners, companies and rounds from sworn filings, firm sites and announcements, kept as a graph with a date and a source on every edge. Facts, inferences and estimates are labelled as such. A fund target is never a close, GAV is never dry powder, and a round size is never an investor’s check.
The names on this page are hidden. Create a free account and they fill in. No card, and every figure, date and source on this page is public either way.
Firms / G•••• H••••••••• P••••••• U•• I•••
G•••• H••••••••• P••••••• U•• I•••
This firm files as 2 advisers on g•••••••••.com: G•••• H••••••••• P••••••• B•••. Each keeps its own CRD, funds and filings; the grouping is the website each swore to on Form ADV and is recomputed every pass.
G•••• H••••••••• is a specialized healthcare investor managing over €3 billion across three fund strategies: Venture&Growth in healthcare, Private Equity in healthcare and Climate Solutions.
venture manager, reported GAV $9.0M across 1 vehicles
Importance
12
low
Active deployment
0
low
Emerging
0
low
Completeness
56
elevated
Freshness
99
high
Research priority
3
low
Identity and regulatory footprint
- Headquarters
- Boston, MAadviserinfo.sec.gov
- Office address
- 575 BOYLSTON STREET, FLOOR 8, Boston, MA, 02142adviserinfo.sec.gov
- Business phone
- 617-395-8245adviserinfo.sec.gov
- Website
- g•••••••••.com
- SEC adviser type
- exempt reporting adviseradviserinfo.sec.gov
- SEC exemption claimed
- venture capital fund adviseradviserinfo.sec.govItem 2.B(1): advises solely venture capital funds
- Latest Form ADV
- Mar 26, 2026
- Private funds reported
- 2 (2 venture capital funds)adviserinfo.sec.gov
- Private fund gross assets
- $81.2Madviserinfo.sec.govreported GAV of the funds, the adviser's own number; not fund size, not dry powder
- Owners on Schedule A
- S•••••••• A••••••••• G•••• H••••••••• H•••••• (Owner), C; M•••••••• B••• (Owner), C; M••••••••• B••• (Owner), C; G•••• H••••••••• H•••••• B••• (Shareholder), E; G•••• H••••••••• P••••••• B• (Parent), E
- business email
- recruitment@gildehealthcare.comgildehealthcare.compublished by the subject
- business email
- healthcare@gildehealthcare.comgildehealthcare.compublished by the subject
- business phone
- 617-395-8245adviserinfo.sec.govpublished by the subject
Stated thesis versus observed behaviour
no observed deals yet
Stated (the firm’s website)
- Sectors
- healthcare, biotech, medtech, climate, energy
- Stages
- not stated or not yet read
- Geography
- boston, europe, germany, north america, united states
- Check size
- not stated; DFX does not estimate checks from round sizes
Observed (from deals on record)
Stage at participation: no observed deals yet
Stage at first entry: no observed deals yet
Sectors: no observed deals yet
lead rate n/afollow-on rate n/anew logos, 12 months 0
Funds and vehicles
1 reported
| Vehicle | Type | Vintage | Lifecycle | Reported GAV | Owners | Form D sold | Latest Form D |
|---|---|---|---|---|---|---|---|
| G•••• H••••••••• I•• C• | Fund | unknown | Unknown | $9.0M Mar 14, 2024 | 2 | unknown | unknown |
GAV is the gross asset value the adviser reported on Form ADV for the vehicle, never the fund’s committed size and never dry powder. Form D sold is the amount sold as of the latest filing, never a final close.
Investment team
3 current, 1 departed
D••• K••••••
Founder or executivePresident · since May 1, 2014
P••••• v•• D•• M•••
Managing partnerBeneficial Owner And Managing Partner And Controlling Person Of S•••••••• A••••••••• G•••• H••••••••• H•••••• · since Jun 1, 2006
E•••• d• G••••
PrincipalDirector · since Apr 1, 2021
1 departed (kept with end dates)
- M••• P••••• · Beneficial Owner · Jun 1, 2006 to Jun 13, 2022 Inference
Investments on record
0 edges, 0 companies, 0 partner-attributed
No investment on record yet. Edges arrive from the firm’s portfolio page, financing announcements, and Form D board seats.
Co-investors
0 relationships from shared deals, counted for the whole firm
No co-investor relationship yet: these are derived only from rounds and portfolio listings the graph has seen both investors on.
Limited partners
0 disclosed
No LP commitment on record. An LP edge needs a public disclosure with a quote: a pension report (see Limited partners for the plans read), a fund announcement naming the LP, or a Form ADV owner. The fund page carries the LP’s reported performance.
Timeline
10 dated events
- Jun 13, 2022M••• P••••• (Beneficial Owner) no longer on Schedule A of G•••• H••••••••• P••••••• U•• I•••
- Jun 13, 2022C••••••••• G•••• H••••••••• I•• U••• first reported on Form ADV by G•••• H••••••••• P••••••• U•• I••• (Venture Capital Fund), GAV $161,950,640Fund first reported on Form ADVFundsFactC••••••••• G•••• H••••••••• I•• U•••SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Jun 13, 2022C••••••••• G•••• H••••••••• I•• U••• no longer reported on Form ADV by G•••• H••••••••• P••••••• U•• I•••Fund no longer reportedFundsInferenceC••••••••• G•••• H••••••••• I•• U•••SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Jun 13, 2022G•••• H••••••••• I• no longer reported on Form ADV by G•••• H••••••••• P••••••• U•• I•••Fund no longer reportedFundsInferenceG•••• H••••••••• I•SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Jun 13, 2022C••••••••• G•••• H••••••••• V• U••• no longer reported on Form ADV by G•••• H••••••••• P••••••• U•• I•••Fund no longer reportedFundsInferenceC••••••••• G•••• H••••••••• V• U•••SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Mar 27, 2020C••••••••• G•••• H••••••••• V• U••• first reported on Form ADV by G•••• H••••••••• P••••••• U•• I••• (Venture Capital Fund), GAV $46,000,000Fund first reported on Form ADVFundsFactC••••••••• G•••• H••••••••• V• U•••SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Mar 27, 2018G•••• H••••••••• I• first reported on Form ADV by G•••• H••••••••• P••••••• U•• I••• (Venture Capital Fund), GAV $275,000,000Fund first reported on Form ADVFundsFactG•••• H••••••••• I•SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Mar 30, 2012G•••• H••••••••• P••••••• U•• I••• first filed Form ADV (ERA, venture capital fund adviser exemption)First SEC adviser filingOrganizationFactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Mar 30, 2012C••••••••• G•••• H••••••••• I•• U••• first reported on Form ADV by G•••• H••••••••• P••••••• U•• I••• (Venture Capital Fund), GAV $130,000,000Fund first reported on Form ADVFundsFactC••••••••• G•••• H••••••••• I•• U•••SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Mar 30, 2012G•••• H••••••••• I•• C• first reported on Form ADV by G•••• H••••••••• P••••••• U•• I••• (Venture Capital Fund), GAV $13,200,000Fund first reported on Form ADVFundsFactG•••• H••••••••• I•• C•SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Classification history
- Sep 12, 2026Micro VC (confirmed, 95%, cls-1)venture manager, reported GAV $9.0M across 1 vehicles
Evidence
58 observations from 3 sources